Chester County News and Community Website
CONSHOHOCKEN, PA — In an important development for patients with non-alcoholic steatohepatitis (NASH), Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced findings from new analyses of the Phase 3 MAESTRO-NASH trial at …
New Data Reinforces Effectiveness of Madrigal’s Rezdiffra in NASH Treatment Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024. The company will present at …
Madrigal Pharmaceuticals to Present at Goldman Sachs Healthcare Conference Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) will present ten data analyses at the European Association for the Study of the Liver (EASL) Congress in Milan, Italy, from June …
Madrigal Pharmaceuticals to Unveil Critical NASH Data at EASL Congress Read More CONSHOHOCKEN, PA — Following an exciting first quarter, Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has reported great strides in both research and financial achievements. Among the most significant is the FDA …
Madrigal’s Pioneering NASH Treatment Receives FDA Approval, Raises $690 Million in Funding Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is set to release its financial outcomes for the first quarter of 2024 on Tuesday, May 7, 2024, before the U.S. markets …
Madrigal Pharmaceuticals to Unveil First-Quarter Results, Hosts Live Webcast Read More